For citations:
Kagan M.Yu., Bervina N.N. Subclinical activity of atypical hemolytic uremic syndrome and eculizumab treatment (Clinical observation). Nephrology and Dialysis. 2015;17(1):52-56. (In Russ.)
Kagan M.Yu., Bervina N.N. Subclinical activity of atypical hemolytic uremic syndrome and eculizumab treatment (Clinical observation). Nephrology and Dialysis. 2015;17(1):52-56. (In Russ.)